Glucotrack has successfully completed its first in-human clinical study for the first real-time, continuous blood glucose monitor (CBGM) placed in the subclavian vein.
Eversense 365 is the world’s first and only one year CGM, which was approved by the United States (US) Food and Drug Administration in September of 2024 and launched across the country in October of ...
15h
The Punch Newspapers on MSNDevices for early detection of stroke, non-communicable diseasesHealth-related technologies have evolved significantly in the modern world, offering people innovative tools to manage their ...
Picture a small, sleek robot following you around the kitchen, helping you multitask—something Apple intends to bring to life ...
Kick off your morning right with these diabetes-friendly breakfast options that are simple to prepare and low in sugar ...
Scientists have created a new low-cost, fast response sensor to detect lung cancer biomarkers, paving the way for the development of screening devices to spot the disease even before symptoms occur.
These days, many devices are programmed through apps on patients’ phones. But the FDA warns that certain phone settings, such ...
Artificial intelligence (AI) is transforming dietary management for diabetes and obesity, offering personalized nutrition plans, real-time glucose mon.
Ever-Growing USA on MSN33m
I Used Gluco Control for 60 Days—Did It Actually Help My Blood Sugar Levels?In today's fast-paced world, maintaining healthy blood sugar levels is crucial for overall well-being. Gluco Control has ...
A nutritious breakfast shortly after waking up is important for managing blood sugar levels - here are five to try ...
Gonzaga University and the UW School of Medicine hosted Irl Hirsch to lecture about the future of glucose monitoring.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results